The COVID-19 pandemic posed many dilemmas for policymakers, which sometimes resulted in unprecedented decision-making

por Ash, Nachman, Triki, Noa, Waitzberg, Ruth
Publicado 2023

Comparison of Mortality and Comorbidity Rates Between Holocaust Survivors and Individuals in the General Population in Israel

por Fund, Naama, Ash, Nachman, Porath, Avi, Shalev, Varda, Koren, Gideon
Publicado 2019

The Israeli Experience with the “Green Pass” Policy Highlights Issues to Be Considered by Policymakers in Other Countries

por Waitzberg, Ruth, Triki, Noa, Alroy-Preis, Sharon, Lotan, Tomer, Shiran, Liat, Ash, Nachman
Publicado 2021

Control of Streptococcus pneumoniae serotype 5 epidemic of severe pneumonia among young army recruits by mass antibiotic treatment and vaccination

por Balicer, Ran D., Zarka, Salman, Levine, Hagai, Klement, Eyal, Sela, Tamar, Porat, Nurith, Ash, Nachman, Dagan, Ron
Publicado 2010

Multi-disciplinary patient-centered model for the expedited provision of costly therapies in community settings: the case of new medication for hepatitis C

por Avisar, Nitzan, Heller, Yael, Weil, Clara, Ben-Baruch, Aviva, Potesman-Yona, Shani, Oren, Ran, Chodick, Gabriel, Shalev, Varda, Ash, Nachman
Publicado 2017

Protection against Covid-19 by BNT162b2 Booster across Age Groups

por Bar-On, Yinon M., Goldberg, Yair, Mandel, Micha, Bodenheimer, Omri, Freedman, Laurence, Alroy-Preis, Sharon, Ash, Nachman, Huppert, Amit, Milo, Ron
Publicado 2021

Protection following BNT162b2 booster in adolescents substantially exceeds that of a fresh 2-dose vaccine

por Amir, Ofra, Goldberg, Yair, Mandel, Micha, Bar-On, Yinon M., Bodenheimer, Omri, Ash, Nachman, Alroy-Preis, Sharon, Huppert, Amit, Milo, Ron
Publicado 2022

Protection and Waning of Natural and Hybrid Immunity to SARS-CoV-2

por Goldberg, Yair, Mandel, Micha, Bar-On, Yinon M., Bodenheimer, Omri, Freedman, Laurence S., Ash, Nachman, Alroy-Preis, Sharon, Huppert, Amit, Milo, Ron
Publicado 2022

BNT162b2 vaccine effectiveness was marginally affected by the SARS-CoV-2 beta variant in fully vaccinated individuals

por Mor, Orna, Zuckerman, Neta S., Hazan, Itay, Fluss, Ronen, Ash, Nachman, Ginish, Netanel, Mendelson, Ella, Alroy-Preis, Sharon, Freedman, Laurence, Huppert, Amit
Publicado 2022

Protection against Omicron BA.1/BA.2 severe disease 0–7 months after BNT162b2 booster

por Amir, Ofra, Goldberg, Yair, Mandel, Micha, Bar-On, Yinon M., Bodenheimer, Omri, Freedman, Laurence, Alroy-Preis, Sharon, Ash, Nachman, Huppert, Amit, Milo, Ron
Publicado 2023

Protection by a Fourth Dose of BNT162b2 against Omicron in Israel

por Bar-On, Yinon M., Goldberg, Yair, Mandel, Micha, Bodenheimer, Omri, Amir, Ofra, Freedman, Laurence, Alroy-Preis, Sharon, Ash, Nachman, Huppert, Amit, Milo, Ron
Publicado 2022

Initial protection against SARS-CoV-2 omicron lineage infection in children and adolescents by BNT162b2 in Israel: an observational study

por Amir, Ofra, Goldberg, Yair, Mandel, Micha, Bar-On, Yinon M, Bodenheimer, Omri, Freedman, Laurence, Ash, Nachman, Alroy-Preis, Sharon, Huppert, Amit, Milo, Ron
Publicado 2023

Waning Immunity after the BNT162b2 Vaccine in Israel

por Goldberg, Yair, Mandel, Micha, Bar-On, Yinon M., Bodenheimer, Omri, Freedman, Laurence, Haas, Eric J., Milo, Ron, Alroy-Preis, Sharon, Ash, Nachman, Huppert, Amit
Publicado 2021

Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel

por Bar-On, Yinon M., Goldberg, Yair, Mandel, Micha, Bodenheimer, Omri, Freedman, Laurence, Kalkstein, Nir, Mizrahi, Barak, Alroy-Preis, Sharon, Ash, Nachman, Milo, Ron, Huppert, Amit
Publicado 2021

Myocarditis after BNT162b2 Vaccination in Israeli Adolescents

por Mevorach, Dror, Anis, Emilia, Cedar, Noa, Hasin, Tal, Bromberg, Michal, Goldberg, Lital, Parnasa, Elchanan, Dichtiar, Rita, Hershkovitz, Yael, Ash, Nachman, Green, Manfred S., Keinan-Boker, Lital, Alroy-Preis, Sharon
Publicado 2022